New Delhi : Bharat Biotech recently received approval from the drug regulator to conduct Phase-3 clinical trials of its nasal vaccine which is being considered as a potential booster dose…
By Raviteja Dodda The rapid adoption of technology, driven by the Covid-19 pandemic, is proving to be a big ‘booster dose’ for the country’s healthcare ecosystem, steering it towards unprecedented…
PATNA: Even as senior citizens and health workers are being administered booster doses at different health centres in the city, people with a recent breakthrough infection are not sure whether…
New Delhi : A surge in coronavirus cases caused by the Omicron variant increasing day by day. Healthcare experts indicate that majority of the people will require booster dose in…
New Delhi: The country on Monday began administering the third ‘precautionary dose’ to three important groups — health care and frontline workers and those aged over 60 years with comorbidities.…
New Delhi : As the country is witnessing a spike in the coronavirus spread driven by its Omicron variant, today the precautionary (booster) COVID-19 vaccine dose will be given to…
Hyderabad : Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, Saturday announced that Covaxin whole-virion inactivated COVID-19 vaccine clinical trial…
Narendra Modi’s announcement on December 25 of a ‘precautionary’ dose – essentially, a third vaccine shot – for Covid-19 healthcare and frontline workers and people above 60 with comorbidities from…
HYDERABAD: With rise in Omicron infections across country, panic-stricken people are taking booster shots illegally at corporate hospitals, some with serious side-effects. This even as experts warn against such actions…
Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version…
